FRLPX Performance — Fidelity Freedom Index 2050 Fund, Premier Class
Data updated: 2026-08-24
FRLPX returned +11.57% year to date and +23.12% over one year to Jun 2026. Annualised returns are +18.15% over 3 years and +9.67% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $165, against $150 for the category, and to $123 over one year, against $118. Volatility over the past three years was 11.73% a year. In the 12 months to Jun 2026 the fund took in a net $3.4B, and assets reached $31.32B.
FRLPX Growth of $100
What $100 invested in Fidelity Freedom Index 2050 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | FRLPX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $123 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $165 | $150 |
| 5 years (Jul 2021 – Jun 2026) | $159 | $143 |
| Since data start (Jul 2020 – Jun 2026) | $215 | $181 |
FRLPX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.57% |
| 1 year | +23.12% |
| 3 years (annualised) | +18.15% |
| 5 years (annualised) | +9.67% |
FRLPX Annual Returns
Calendar-year total returns of Fidelity Freedom Index 2050 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +11.57% |
| 2025 | +21.47% |
| 2024 | +14.19% |
| 2023 | +20.01% |
| 2022 | −18.17% |
| 2021 | +16.00% |
| 2020 (Jul–Dec) | +22.02% |
FRLPX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.9% | +1.9% | −6.0% | +8.6% | +4.4% | 0.0% | — | — | — | — | — | — |
| 2025 | +3.1% | +0.1% | −3.2% | +0.7% | +4.9% | +4.3% | +0.8% | +2.7% | +3.5% | +2.0% | +0.2% | +0.9% |
| 2024 | −0.1% | +3.9% | +3.0% | −3.6% | +4.2% | +1.6% | +2.2% | +2.3% | +2.1% | −2.5% | +3.6% | −2.9% |
| 2023 | +7.3% | −3.1% | +2.8% | +1.2% | −1.2% | +5.3% | +3.1% | −2.8% | −4.3% | −3.0% | +8.8% | +5.3% |
| 2022 | −4.4% | −2.7% | +1.3% | −7.8% | +0.4% | −7.6% | +6.6% | −3.9% | −9.2% | +5.4% | +8.3% | −4.2% |
| 2021 | −0.3% | +2.2% | +2.2% | +3.9% | +1.4% | +1.4% | +0.5% | +2.1% | −3.9% | +4.7% | −2.2% | +3.3% |
| 2020 | — | — | — | — | — | — | +4.7% | +5.2% | −2.7% | −2.1% | +11.4% | +4.4% |
FRLPX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 11.73%
- 3-year Sharpe ratio: 1.16 (vs 4.5% risk-free rate)
- Best month: +8.77% (Nov 2023)
- Worst month: −6.05% (Mar 2026)
FRLPX Fund Flows
Monthly money in and out of Fidelity Freedom Index 2050 Fund, from SEC Form N-PORT.
- 12-month net flow: $3.4B
- 12-month gross sales (incl. reinvestments): $12.2B
- Sales ÷ redemptions: 1.39×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $1.0B | $587.3M | $429.1M |
| May 2026 | $722.8M | $475.0M | $247.7M |
| Apr 2026 | $1.3B | $926.5M | $341.1M |
| Mar 2026 | $1.2B | $630.6M | $551.6M |
| Feb 2026 | $997.8M | $726.7M | $271.1M |
| Jan 2026 | $1.3B | $946.0M | $313.3M |
| Dec 2025 | $2.5B | $1.8B | $660.2M |
| Nov 2025 | $556.0M | $427.8M | $128.2M |
| Oct 2025 | $677.3M | $547.8M | $129.6M |
| Sep 2025 | $777.0M | $669.1M | $107.8M |
| Aug 2025 | $640.2M | $579.4M | $60.8M |
| Jul 2025 | $611.6M | $414.3M | $197.3M |
FRLPX Assets Under Management
Net assets of Fidelity Freedom Index 2050 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $31.32B |
| 2026-03-31 | $26.72B |
| 2025-12-31 | $26.01B |
| 2025-09-30 | $24.83B |
| 2025-06-30 | $22.83B |
| 2025-03-31 | $20.19B |
| 2024-12-31 | $19.83B |
| 2024-09-30 | $19.69B |
| 2024-06-30 | $18.06B |
| 2024-03-31 | $17.33B |
| 2023-12-31 | $15.76B |
| 2023-09-30 | $13.64B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.